# Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers

**Authors:** Ayman Alzu’bi, Ejlal Abu-El-Rub, Ramada R. Khaswaneh, Mohammed Al-Zubaidi, Wissam Almomani, Abdelrahman Alenaizat, Adnan H. Ayyash, Anas Alragheb, Anas Alshannag, Enas Ahmad, Mai Elaarag, Raed M. Al-Zoubi

PMC · DOI: 10.1007/s12265-026-10762-y · Journal of Cardiovascular Translational Research · 2026-03-09

## TL;DR

This study shows that vaping disrupts circadian proteins and increases inflammation, similar to patterns seen in cardiovascular disease, suggesting a link to higher heart risk.

## Contribution

The study identifies a novel mechanistic link between e-cigarette use and cardiovascular risk through circadian disruption and inflammation.

## Key findings

- Vaping significantly reduced levels of circadian proteins like Melatonin, PER1, PER2, CRY1, and CRY2.
- Vapers showed elevated inflammatory and oxidative stress markers (IFN-γ, MDA) similar to cardiovascular disease patients.
- The observed molecular changes suggest a potential mechanism linking vaping to increased cardiovascular risk.

## Abstract

The increasing popularity of E-cigarettes among young adults has raised concerns about their health effects, particularly on the circadian system, which regulates critical physiological processes. This study examined how vaping influences circadian proteins and inflammatory markers, comparing these effects to those in cardiovascular disease patients. Blood samples from 254 participants, non-vaping controls (n = 90), regular vapers (n = 86), and cardiovascular patients (n = 78), were analyzed for circadian proteins (Melatonin, BMAL1, PER1, PER2, CRY1, CRY2) and inflammatory/oxidative stress markers (IFN-γ, MDA). Vaping significantly decreased Melatonin, PER1, PER2, CRY1, and CRY2, while BMAL1 remained unchanged. Elevated IFN-γ and MDA levels indicated increased inflammation and oxidative stress in vapers. Vaping induces circadian disruption patterns similar to cardiovascular disease, suggesting a potential mechanism linking e-cigarette use to increased cardiovascular risk.

The figure illustrates a progression from vaping exposure toincreased cardiovascular risk. Vaping introduces nicotine and harmful chemicals (low risk stage), leading todisruption of circadian clock proteins (reduced melatonin, PER1/2, CRY1/2; unchanged BMAL1) and elevatedinfl ammatory and oxidative stress markers (IFN-γ, MDA). These molecular alterations resemble patterns observed incardiovascular disease, suggesting a mechanistic link between e-cigarette use and heightened cardiovascular risk.

The figure illustrates a progression from vaping exposure toincreased cardiovascular risk. Vaping introduces nicotine and harmful chemicals (low risk stage), leading todisruption of circadian clock proteins (reduced melatonin, PER1/2, CRY1/2; unchanged BMAL1) and elevatedinfl ammatory and oxidative stress markers (IFN-γ, MDA). These molecular alterations resemble patterns observed incardiovascular disease, suggesting a mechanistic link between e-cigarette use and heightened cardiovascular risk.

## Linked entities

- **Proteins:** BMAL1 (basic helix-loop-helix ARNT like 1), PER1 (period circadian regulator 1), PER2 (period circadian regulator 2), CRY1 (cryptochrome circadian regulator 1), CRY2 (cryptochrome circadian regulator 2), IFNG (interferon gamma)
- **Diseases:** cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** PER3 (period circadian regulator 3) [NCBI Gene 8863] {aka FASPS3, GIG13}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, PER2 (period circadian regulator 2) [NCBI Gene 8864] {aka FASPS, FASPS1}, CAT (catalase) [NCBI Gene 847], CRY2 (cryptochrome circadian regulator 2) [NCBI Gene 1408] {aka HCRY2, PHLL2}, CRY1 (cryptochrome circadian regulator 1) [NCBI Gene 1407] {aka DSPD, PHLL1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, PER1 (period circadian regulator 1) [NCBI Gene 5187] {aka PER, RIGUI, hPER}
- **Diseases:** hypertension (MESH:D006973), reperfusion injury (MESH:D015427), infections (MESH:D007239), CVDs (MESH:D002318), cardiac damage (MESH:D006331), bacterial infections (MESH:D001424), heart failure (MESH:D006333), chronic illness (MESH:D002908), mitochondrial dysfunction (MESH:D028361), Inflammation (MESH:D007249), incardiovascular disease (MESH:D004194), pressure overload (MESH:D019190), fibrosis (MESH:D005355), Vaping Disrupts (MESH:D019958), insomnia disorder (MESH:D007319), psychiatric disorders (MESH:D001523), alcohol and drug abuse (MESH:D019966), myocardial damage (MESH:D009202), tobacco addicted (OMIM:188890), autonomic dysfunction (MESH:D001342), ischemia (MESH:D007511), neurological disorders (MESH:D009461)
- **Chemicals:** Melatonin (MESH:D008550), nicotine (MESH:D009538), MDA (MESH:D008315), fatty acid (MESH:D005227), lipid (MESH:D008055), ROS (MESH:D017382), TBARS (MESH:D017392), triglycerides (MESH:D014280), MDA (MESH:D015104), thiobarbituric acid (MESH:C029684), E- (MESH:D004540)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971915/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971915/full.md

---
Source: https://tomesphere.com/paper/PMC12971915